Projections indicate a substantial rise in global health challenges, with the number of individuals living with dementia expected to nearly triple by 2050, reaching an estimated 153 million people worldwide. Despite this alarming forecast, experts suggest that a significant portion of these cases could potentially be prevented or delayed. New research presented at a major international heart health conference highlighted a potential protective role for cholesterol-lowering medications in mitigating the risk of dementia.
The findings stem from a comprehensive study conducted in Denmark, which tracked over 132,000 patients between 2006 and 2021. The analysis specifically investigated the impact of statin use. According to the study’s results, patients who began taking statins during the observation period demonstrated a 10% lower likelihood of developing dementia compared to those who did not.
Furthermore, the research indicated that initiating statin therapy at an earlier stage reduced this associated risk by 15%. These protective correlations were observed consistently across both male and female participants. These findings suggest that cardiovascular management may play a role in cognitive health outcomes.
The research underscores the importance of preventative care related to heart health, suggesting that controlling cholesterol levels could represent a viable strategy in managing the growing global burden of dementia.
Topics: #dementia #study #almost
